Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Medicenna Therapeutics Corp. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 26 | 25 | −1 |
| Shares | 5.02M | 3.05M | −1.97M (−39.3%) |
| Value | $15.4M | $8.66M | −$6.73M (−43.7%) |
New holders (7)
Institutions that held Medicenna Therapeutics Corp. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Letko, Brosseau & Associates Inc | 100,000 | $277.0K | 0.00% |
| Vident Investment Advisory, LLC | 62,880 | $172.0K | 0.01% |
| Sigma Planning Corp | 30,500 | $84.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 12,915 | $36.0K | 0.01% |
| K.J. Harrison & Partners Inc | 10,000 | $27.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,666 | $5.00K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 1 | – | – |
Sold out (8)
Institutions that held Medicenna Therapeutics Corp. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| AWM Investment Company, Inc. | 1,000,000 | $3.02M |
| Board of Trustees of The Leland Stanford Junior University | 962,932 | $2.90M |
| Silverarc Capital Management, LLC | 110,515 | $333.0K |
| Maven Securities LTD | 79,118 | $234.0K |
| JPMorgan Chase & Co | 25,500 | $77.0K |
| Citadel Advisors LLC | 24,203 | $73.0K |
| Federation des caisses Desjardins du Quebec | 1,000 | $2.98K |
| Bank of America Corp | 19 | $0 |